Quick Facts
- Sample: Blood and urine
- Fasting: Not required (overnight fasting may improve accuracy)
- Turn-around: 1-2 days. May take longer based on weather, holiday, or lab delays.
Benefits
- Comprehensive fertility assessment - measures key reproductive hormones and biomarkers in one panel
- No doctor referral needed - direct access testing eliminates appointment delays and consultation fees
- Early detection capabilities - identifies hormone imbalances before they impact conception attempts
- At-home convenience - finger-prick collection option with secure, confidential online results
- Expert interpretation - board-certified physicians review all results and provide guidance
- Cost-effective solution - reduces overall testing expenses compared to traditional clinic pathways
Who Is This Test For?
- Women trying to conceive or planning pregnancy within the next year
- Individuals with irregular menstrual cycles or missed periods
- Women over 35 who want to assess their fertility potential
- Those with PCOS, endometriosis, or thyroid condition symptoms
- Individuals experiencing unexplained difficulty getting pregnant after 6-12 months
- Women wanting baseline fertility health assessment before family planning
How It Works – Just 3 Steps
Order online - no prescription required; schedule lab visit or request at-home kit
Provide samples -blood draw at lab facility or finger-prick collection at home
Get results - secure online portal delivers results in 1-2 business days
FAQ
What hormones does this panel test? TSH, progesterone, estradiol, Free T4, prolactin, total estrogen, FSH, LH, DHEA-S, and total testosterone, plus complete urinalysis.
When during my cycle should I test? Day 2-3 for most hormones (FSH, LH, estradiol); day 19-21 for progesterone; other hormones can be tested anytime.
How accurate are the results? AMH testing shows 80% sensitivity and 78.95% specificity for ovarian reserve assessment, significantly outperforming FSH testing (clinical research 2015).
Do I need to prepare for this test? No fasting required for most hormones, though overnight fasting may improve accuracy; stay well-hydrated before blood draw.
Can this test diagnose infertility? This panel identifies hormone imbalances and fertility factors; comprehensive evaluation by a reproductive specialist determines infertility diagnosis.
What if my results are abnormal? Schedule follow-up with your doctor or reproductive endocrinologist within 2-4 weeks for interpretation and potential treatment planning.
More Details
What is the purpose of this test?
This comprehensive panel evaluates reproductive hormone levels, ovarian reserve, and overall health factors that impact fertility. It measures essential hormones regulating menstrual cycles, ovulation, and pregnancy preparation while screening for conditions like thyroid dysfunction, PCOS, and hormonal imbalances that affect conception ability.
With 17.5% of adults globally experiencing infertility (WHO 2023) and 13.4% of US women having impaired fecundity (CDC 2024), this testing provides crucial early detection and proactive reproductive health insights.
Who would benefit from this test?
Women experiencing difficulty conceiving after 6-12 months of trying benefit most from comprehensive fertility assessment. The American Society for Reproductive Medicine (ASRM 2021) recommends fertility evaluation after 12 months for women under 35 and 6 months for women 35 and older.
This panel also helps women with irregular cycles, PCOS symptoms, thyroid concerns, or those planning pregnancy timing around career goals. Additionally, it provides valuable baseline assessment for women wanting to understand their fertility status before attempting conception.
When should I order Female Fertility Blood and Urine Test Panel?
Order this panel when experiencing irregular or missed periods, difficulty conceiving after appropriate timeframes, or symptoms suggesting hormonal imbalances. Optimal timing is day 2-3 of your menstrual cycle for most hormones, with progesterone testing on day 19-21 (reproductive timing guidelines).
Consider testing if you have unexplained fatigue, weight changes, excess hair growth, mood swings, or family history of fertility issues. Early assessment allows proactive treatment of identified conditions before they significantly impact conception attempts.
How do I interpret the results?
Results compare your hormone levels to established reference ranges for reproductive-age women. Abnormal levels may indicate specific fertility-affecting conditions requiring medical consultation.
AMH: 0.7–3.5 ng/mL
- Low: Diminished ovarian reserve
- High: PCOS risk
FSH (day 3): <9–12 IU/L
- Elevated (>10–15): Reduced egg quantity/quality
LH: 1–12 IU/L
- Elevated: May suggest PCOS or ovulation issues
TSH: 0.4–4.0 mIU/L
- Outside range: Thyroid dysfunction affecting fertility
Reference ranges vary by age and laboratory; AMH naturally declines with aging, making early assessment valuable for family planning.
Disclaimer: Reference ranges may vary by laboratory. Listed ranges are general guidelines and may differ from those used by the performing lab. Always consult your healthcare provider for interpretation.
Pre-test preparation
No special preparation is required for most fertility hormones, though overnight fasting may improve test accuracy. Stay well-hydrated before your blood draw to facilitate sample collection. Inform your healthcare provider about any hormonal medications, birth control, or fertility treatments, as these may affect results.
Schedule your test for the appropriate menstrual cycle day based on which hormones are being measured. Most require day 2-3 timing, while progesterone needs mid-luteal phase (day 19-21) testing for accurate assessment.
How often should I get tested?
- Initial fertility assessment: Once, then as directed by physician
- Monitoring treatment response: Every 3–6 months during treatment
- Age-related fertility tracking: Annually after age 35
- PCOS or thyroid management: Every 6–12 months or as prescribed
Why early detection matters
Early identification of fertility-affecting conditions significantly improves treatment outcomes and pregnancy success rates. For example, 76.6% of infertile women with hypothyroidism conceived within 6 weeks to 1 year after treatment (medical research 2000), demonstrating the importance of timely diagnosis.
PCOS affects 6-13% of reproductive-aged women globally, with up to 70% remaining undiagnosed (WHO 2025). Early detection enables lifestyle modifications and medical interventions that can restore ovulation and improve fertility outcomes before attempting conception.
Related tests you may consider
Anti-Mullerian Hormone (AMH) Blood Test (Female Only) - Assesses women's fertility and reproductive health by measuring AMH levels in the blood.
Cardio IQ® Insulin Resistance Panel with Score Blood Test- Gives you information to change or avoid becoming diabetic or prediabetic.
Thyroid #3 Extreme Blood Test Panel- Provides a detailed evaluation of thyroid function and detects the number of specific thyroid antibodies in the blood of individuals showcasing signs of thyroid disorder.
